Skip to main content

Multiple Sclerosis

  • Chapter
  • First Online:
Uveitis

Abstract

Multiple sclerosis is a chronic demyelinating disease primarily affecting the CNS. There is episodic reversible neurologic dysfunction. It has a variable clinical course and unpredictable course with four major categories: relapsing-remitting (85%), secondary progressive, primary progressive (10%), and progressive-relapsing (5%). Ocular disease presents as optic neuritis, uveitis, or neuro-ophthalmological disease. The majority of patients may show excellent recovery; permanent visual disability is possible if not treated adequately. Seventy-two percent of patients with MRI abnormalities convert to multiple sclerosis within 15 years.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Quan Dong Nguyen .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Nguyen, Q.D., Hassan, M., Agarwal, A. (2021). Multiple Sclerosis. In: Foster, C.S., Anesi, S.D., Chang, P.Y. (eds) Uveitis. Springer, Cham. https://doi.org/10.1007/978-3-030-52974-1_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-52974-1_12

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-52973-4

  • Online ISBN: 978-3-030-52974-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics